Results 11 to 20 of about 28,042 (215)

Cellular and Molecular Differences between HFpEF and HFrEF: A Step Ahead in an Improved Pathological Understanding

open access: yesCells, 2020
Heart failure (HF) is the most rapidly growing cardiovascular health burden worldwide. HF can be classified into three groups based on the percentage of the ejection fraction (EF): heart failure with reduced EF (HFrEF), heart failure with mid-range—
Steven J. Simmonds   +3 more
doaj   +2 more sources

Atrial Fibrillation and HFrEF: Cause, Consequence, or Both? [PDF]

open access: yesBiomedicines
Background/Objectives: Atrial fibrillation (AF) and heart failure with reduced ejection fraction (HFrEF) frequently coexist and are linked by shared risk factors and pathophysiological mechanisms.
Grigore M   +7 more
europepmc   +2 more sources

Comparison of sarcopenia prevalence and prognostic features between HFrEF and HFpEF: a systematic review and meta-analysis [PDF]

open access: yesFrontiers in Cardiovascular Medicine
BackgroundSarcopenia is closely associated with heart failure (HF); however, no prior meta-analysis has specifically addressed its relation with different ejection fraction phenotypes. This study investigated the prevalence of sarcopenia in patients with
Weizhu Xiong   +5 more
doaj   +2 more sources

CPET Characteristics in HFrEF, HFpEF and COPD. [PDF]

open access: yesJ Clin Med
Chronic obstructive pulmonary disease (COPD) frequently occurs alongside heart failure (HF), including heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF), creating a diagnostic dilemma due to ...
Zhou Y, Wang G, Wu X.
europepmc   +2 more sources

Development of new HFrEF–univariate logistic regression.

open access: yes, 2023
Development of new HFrEF–univariate logistic regression.
Udi Nussinovitch (16436579)   +4 more
core   +1 more source

Treating Patients with HFrEF; Overcoming Clinical Inertia

open access: yes
The management of heart failure with reduced left ventricular ejection fraction (HFrEF) isbased on a large number of randomised clinical trials (RCTs) including many thousands ofpatients, demonstrating the clinical benefit of inhibitors of the renin ...
Iain Squire (20342103)
core   +5 more sources

Exploring the mechanisms underlying stroke volume variability reduction in a murine model of heart failure with reduced ejection fraction.

open access: yesPLoS ONE, 2023
Heart failure with reduced ejection fraction (HFrEF) is accompanied by disregulation of cardiovascular function. Heart rate variability (HRV) is commonly used to assess autonomic dysfunction in HFrEF.
Gemma Fernández-Mendoza   +4 more
doaj   +1 more source

The association of obesity and cardiometabolic traits with incident hfpef and hfref [PDF]

open access: yes, 2018
Objectives:  This study evaluated the associations of obesity and cardiometabolic traits with incident heart failure with preserved versus reduced ejection fraction (HFpEF vs. HFrEF).
Zanni, M.V.   +25 more
core   +3 more sources

Effects of diabetes mellitus on left ventricular function and remodeling in hypertensive patients with heart failure with reduced ejection fraction: assessment with 3.0 T MRI feature tracking

open access: yesCardiovascular Diabetology, 2022
Background Heart failure with reduced ejection fraction (HFrEF) is a major health burden worldwide with high morbidity and mortality. Comorbidities of HFrEF complicate treatment and lead to poor prognosis, among which hypertension (HTN) and diabetes ...
Ge Zhang   +6 more
doaj   +1 more source

A novel age-biomarker-clinical history prognostic index for heart failure with reduced left ventricular ejection fraction

open access: yesOpen Medicine, 2020
A model for predicting the prognosis of patients with heart failure with reduced left ventricular ejection fraction (HFrEF) is currently not available. This study aimed to develop an age-biomarker-clinical history prognostic index (ABC-PI) and validate ...
Li Hao   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy